Can ctDNA Measurements Predict DLBCL Outcomes?

A study shows pretreatment ctDNA levels and molecular responses are independently prognostic of outcomes in lymphomas.

Source: CancerNetwork - September 13, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news